Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

by Medical Finance
in Coronavirus
Study: Effect of vaccination rates on the prevalence and mortality of COVID-19. Image Credit: hvostik/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Researchers in Australia have investigated coronavirus disease 2019 (COVID-19) vaccine effectiveness on the prevalence and mortality of the Delta variant. They found that countries with more vaccine coverage suffer from less mortality. However, the case numbers remain high, eventually leading to outbreaks. The team attributes the scenario to the fact that the countries with more vaccine coverage are at the same time the most vulnerable to COVID-19 infection.

Study: Effect of vaccination rates on the prevalence and mortality of COVID-19. Image Credit: hvostik/Shutterstock
Study: Effect of vaccination rates on the prevalence and mortality of COVID-19. Image Credit: hvostik/Shutterstock

Also, when many countries were geared up with high vaccination coverage, the case numbers and the deaths were still rising over time. The team suggests that the waning of the protective vaccine antibodies could be the most probable reason behind this phenomenon.

A preprint version of the research paper is available on the medRxiv* server while the article undergoes peer review.

Background

Although implementing strict non-pharmaceutical interventions (NPI) and the use of protective vaccines, the control of COVID-19 infection has been a challenge. The situation is driven by the emergence of new viral variants with immune escape capacity and the waning of the immunity induced by the vaccinations.

Reports show that while the immunity against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection wanes in less than one year of receiving a two-dose vaccination series, the protection against the severe disease and death still exists.

Two previous studies had reported a lack of association between the SARS-CoV-2 vaccination coverage and the daily cases.

To analyze even more deeply for assessing the global effect of control measures on mitigating the COVID-19 infection, the current study investigated a larger data set from 190 countries.

What did the researchers do?

The team collected data for 190 countries from March 1st, 2021, to December 1st, 2021. Publicly available repositories were used to extract the number of daily cases and deaths, the stringency index, the vaccine coverage, human development index (HDI), and the population of respective countries.

The trends were analyzed within three-month time-frame windows, as the time frame is sufficient to track the dynamics of the disease as well as large enough to curtail the noise from any smaller outbreaks. A moving average line was used to show the trends of the pandemic.

What did the researchers find?

Even for countries with very similar vaccination coverage, the daily cases per capita differed substantially, suggesting that the vaccination rate was not associated with the prediction of daily cases.

The team also observed that after reaching a certain vaccination level, the countries receiving higher vaccine doses per person suffered lower daily deaths per million, indicating that the deaths per case decline with vaccination.

Interestingly, the pre-vaccination trends showed that developing countries were not the most affected by the COVID-19 pandemic. Still, the richer a country was, the higher the incidences and deaths it suffered from the disease. Based on the trends of HDI vs. cases/deaths, the team suggested that wealthier countries with more vaccination coverage are also the more susceptible ones to the disease and hence suffer more in the pandemic.

Overall, the team did not find any significant evidence of vaccines effectively reducing the prevalence of infections, which contradicts the claims of reducing the chances of infection by the COVID-19 vaccines in clinical trials. The team later attributes this to the declining population immunity resulting from waning vaccine-induced protective antibodies.

It seems that vaccines cannot end the pandemic, but they can likely reduce the deaths caused by the pandemic to a very low level of mortality,” concludes the team.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Inpatient COVID-19 Mortality Rates: What are the predictors?. Image Credit: CKA/ Shutterstock

What are the predictors of inpatient COVID-19 mortality rates?

by Medical Finance
May 20, 2022
0

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a severe infection that spreads swiftly within a population and has put...

Study: VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance. Image Credit: Kateryna Kon/Shutterstock

VarLOCK approach for rapid detection of SARS-CoV-2 variants of concern and wastewater monitoring

by Medical Finance
May 20, 2022
0

A recent preprint study posted to the medRxiv* server discussed the expansion of the severe acute respiratory syndrome coronavirus...

Study: A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections. Image Credit: Design_Cells / Shutterstock

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

by Medical Finance
May 20, 2022
0

Among the various viral diseases, two of the most prevalent viruses that have affected millions of lives are severe acute...

Study: Comparison of Moderna Versus Pfizer-Biontech COVID-19 Vaccine Outcomes: A Target Trial Emulation Study In the U.S. Veterans Affairs Healthcare System. Image Credit: BaLL LunLa/Shutterstock

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

by Medical Finance
May 20, 2022
0

Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed to combat the ongoing coronavirus disease 2019...

Long-term exposure to air pollutants may increase the incidence of COVID-19

Long-term exposure to air pollutants may increase the incidence of COVID-19

by Medical Finance
May 20, 2022
0

Long term exposure to ambient air pollution may heighten the risk of COVID-19 infection, suggests research published online in the...

Study: Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Image Credit: CROCOTHERY/Shutterstock

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

by Medical Finance
May 20, 2022
0

In a study posted recently to the bioRxiv* preprint server, researchers determined the early immune response to severe acute respiratory...

Next Post
E Coli

How could AI be used to predict infection outcomes?

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: SARS-CoV-2 spike variants differ in their allosteric response to linoleic acid. Image Credit: Naeblys/Shutterstock
    The response of four SARS-CoV-2 spike variants to linoleic acid removal
  • shutterstock 2113587182
    Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply